OMERS ADMINISTRATION Corp Buys 2,225 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

OMERS ADMINISTRATION Corp lifted its stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 1.3% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 171,121 shares of the healthcare conglomerate's stock after buying an additional 2,225 shares during the period. OMERS ADMINISTRATION Corp's holdings in UnitedHealth Group were worth $86,563,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Western Pacific Wealth Management LP boosted its stake in UnitedHealth Group by 2.2% in the 4th quarter. Western Pacific Wealth Management LP now owns 902 shares of the healthcare conglomerate's stock valued at $456,000 after buying an additional 19 shares in the last quarter. MCF Advisors LLC raised its stake in shares of UnitedHealth Group by 0.8% in the fourth quarter. MCF Advisors LLC now owns 2,578 shares of the healthcare conglomerate's stock valued at $1,304,000 after acquiring an additional 20 shares during the last quarter. Axiom Financial Strategies LLC grew its position in UnitedHealth Group by 3.6% during the 4th quarter. Axiom Financial Strategies LLC now owns 575 shares of the healthcare conglomerate's stock worth $291,000 after acquiring an additional 20 shares during the last quarter. Richwood Investment Advisors LLC raised its position in UnitedHealth Group by 0.4% in the 4th quarter. Richwood Investment Advisors LLC now owns 5,247 shares of the healthcare conglomerate's stock valued at $2,654,000 after purchasing an additional 20 shares during the last quarter. Finally, 44 Wealth Management LLC grew its holdings in UnitedHealth Group by 1.6% during the 4th quarter. 44 Wealth Management LLC now owns 1,309 shares of the healthcare conglomerate's stock worth $662,000 after acquiring an additional 21 shares during the last quarter. 87.86% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Several brokerages have recently issued reports on UNH. Morgan Stanley cut their price target on UnitedHealth Group from $664.00 to $563.00 and set an "overweight" rating on the stock in a research note on Tuesday, April 22nd. Truist Financial cut their price target on shares of UnitedHealth Group from $660.00 to $580.00 and set a "buy" rating on the stock in a research report on Monday, April 21st. Robert W. Baird reduced their price target on shares of UnitedHealth Group from $640.00 to $510.00 and set an "outperform" rating for the company in a report on Tuesday, April 29th. KeyCorp reduced their price target on UnitedHealth Group from $650.00 to $575.00 and set an "overweight" rating for the company in a research report on Monday, April 21st. Finally, HSBC reissued a "hold" rating and set a $490.00 price target on shares of UnitedHealth Group in a research report on Tuesday, April 22nd. Four research analysts have rated the stock with a hold rating, nineteen have issued a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average price target of $596.86.

UnitedHealth Group Stock Down 0.6%

NYSE UNH opened at $378.42 on Tuesday. UnitedHealth Group Incorporated has a 1-year low of $335.31 and a 1-year high of $630.73. The company has a 50 day moving average of $486.06 and a 200-day moving average of $520.74. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The company has a market cap of $343.28 billion, a price-to-earnings ratio of 24.41, a PEG ratio of 1.37 and a beta of 0.56.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing the consensus estimate of $7.29 by ($0.09). UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The company had revenue of $109.58 billion for the quarter, compared to the consensus estimate of $111.56 billion. During the same period last year, the firm posted $6.91 earnings per share. On average, equities research analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th were given a dividend of $2.10 per share. The ex-dividend date was Monday, March 10th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 2.22%. UnitedHealth Group's dividend payout ratio (DPR) is 35.18%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.